• Thumbnail for Cancer immunotherapy
    Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight...
    92 KB (12,517 words) - 05:38, 1 October 2024
  • for its potential to treat various forms of cancer. Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes...
    59 KB (6,137 words) - 22:03, 11 October 2024
  • Thumbnail for Cancer immunology
    development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance...
    33 KB (3,766 words) - 14:14, 19 June 2024
  • Thumbnail for PD-1 and PD-L1 inhibitors
    PD-1 and PD-L1 inhibitors (category Cancer immunotherapy)
    non-small cell lung cancer, renal cell carcinoma, bladder cancer and Hodgkin lymphoma, amongst other cancer types. Immunotherapy with these immune checkpoint...
    35 KB (3,450 words) - 03:38, 30 September 2024
  • Stojdl DF, Bell JC (August 2014). "Going viral with cancer immunotherapy". Nature Reviews. Cancer. 14 (8): 559–67. doi:10.1038/nrc3770. PMID 24990523...
    72 KB (8,636 words) - 02:42, 17 November 2024
  • Thumbnail for James P. Allison
    James P. Allison (category University of Texas MD Anderson Cancer Center faculty)
    and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas. Allison is Regental Professor...
    25 KB (2,142 words) - 14:45, 30 August 2024
  • Thumbnail for Atezolizumab
    for bladder cancer. Food and Drug Administration (FDA). In the European Union, atezolizumab is the first PD-(L)1 cancer immunotherapy for subcutaneous...
    43 KB (4,183 words) - 04:17, 1 October 2024
  • Thumbnail for Sean Parker
    2016, the Parker Institute for Cancer Immunotherapy scientists funded a clinical trial to test the next wave of cancer-fighting T-cells engineered using...
    69 KB (5,701 words) - 10:27, 17 November 2024
  • S2CID 26656379. Cancer Immunotherapy Consortium (coordinated early-phase clinical trials of therapeutic cancer vaccines) Society for Immunotherapy of Cancer Association...
    28 KB (3,212 words) - 04:50, 2 November 2024
  • Thumbnail for Interferon gamma
    chromosomal locus. Type II IFN has played a role in the development of cancer immunotherapy treatments due to its ability to prevent tumor growth. IFNG, or type...
    56 KB (6,483 words) - 07:29, 6 November 2024
  • Thumbnail for BioNTech
    on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement...
    53 KB (4,254 words) - 14:51, 14 November 2024
  • Thumbnail for Cancer treatment
    Other therapies include hyperthermia, immunotherapy, photodynamic therapy, and stem-cell therapy. Most commonly cancer treatment involves a series of separate...
    70 KB (8,435 words) - 06:51, 19 October 2024
  • The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional...
    11 KB (1,064 words) - 23:12, 27 September 2024
  • clinical cancer research shifted towards therapies derived from biotechnology research, such as cancer immunotherapy and gene therapy. Cancer research...
    45 KB (5,930 words) - 09:05, 20 November 2024
  • Thumbnail for Non-small-cell lung cancer
    First Immunotherapy Treatment for Lung Cancer - NCI". www.cancer.gov. 24 March 2015. Retrieved 22 September 2023. "Approvals Increase Lung Cancer Treatment...
    51 KB (5,336 words) - 08:52, 11 November 2024
  • Thumbnail for Stomach cancer
    therapy, and targeted therapy. For certain subtypes of gastric cancer, cancer immunotherapy is an option as well. If treated late, palliative care may be...
    76 KB (7,890 words) - 08:04, 11 November 2024
  • Thumbnail for Adenosine A2A receptor
    response. Blockade of A2AR has been attempted to various ends, namely cancer immunotherapy. While several A2A receptor antagonists have progressed to clinical...
    46 KB (5,133 words) - 08:40, 23 September 2024
  • Thumbnail for Merck & Co.
    health products. It has several blockbuster products, including cancer immunotherapy, anti-diabetic medications, and vaccines for HPV and chickenpox,...
    99 KB (9,725 words) - 08:33, 17 November 2024
  • Thumbnail for William Coley
    William Coley (category American cancer researchers)
    an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection...
    17 KB (1,930 words) - 05:14, 4 November 2024
  • Sipuleucel-T (category Wikipedia articles incorporating text from the National Cancer Institute Dictionary of Cancer Terms)
    Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). It is an autologous cellular immunotherapy. Sipuleucel-T is indicated for...
    16 KB (1,405 words) - 17:07, 25 November 2023
  • The Breakthrough: Immunotherapy and the Race to Cure Cancer is a non-fiction book written by American journalist and author Charles Graeber. The book...
    6 KB (606 words) - 05:26, 22 March 2023
  • Thumbnail for Tasuku Honjo
    this discovery significantly contributed to the establishment of cancer immunotherapy principle by PD-1 blockade. Honjo has received several awards and...
    15 KB (1,524 words) - 11:24, 18 November 2024
  • Individualized cancer immunotherapy, also referred to as individualized immuno-oncology, is a novel concept for therapeutic cancer vaccines that are truly...
    25 KB (2,535 words) - 09:22, 8 April 2023
  • Thumbnail for Pembrolizumab
    Pembrolizumab (category Cancer immunotherapy)
    Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain...
    80 KB (7,412 words) - 02:30, 16 October 2024
  • Cancer Immunology, Immunotherapy is a monthly peer-reviewed medical journal published by Springer Science+Business Media. According to the Journal Citation...
    2 KB (169 words) - 14:31, 29 April 2023
  • Checkpoint inhibitor (category Cancer immunotherapy)
    Checkpoint inhibitor therapy is a form of cancer immunotherapy. The therapy targets immune checkpoints, key regulators of the immune system that when stimulated...
    21 KB (2,093 words) - 02:41, 1 September 2024
  • Thumbnail for Survivin
    target of attention in recent years for cancer immunotherapy, as it is an antigen that is expressed mostly in cancer cells and absent in normal cells. This...
    62 KB (8,391 words) - 07:31, 28 October 2024
  • Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous...
    45 KB (4,175 words) - 04:23, 25 September 2024
  • mRNA encoding cancer antigens by BioNTech has started with patients with melanoma (NCT01684241). Recently, the new cancer immunotherapy, the combining...
    77 KB (8,887 words) - 03:21, 29 October 2024
  • Thumbnail for Cellular adoptive immunotherapy
    Cellular adoptive immunotherapy is a type of immunotherapy. Immune cells such as T-cells are usually isolated from patients for expansion or engineering...
    19 KB (2,170 words) - 03:58, 19 September 2024